Is Endocan a Novel Potential Biomarker of Liver Steatosis and Fibrosis?

Journal of Medical Biochemistry - Serbia
doi 10.2478/jomb-2019-0042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Related search

Sipa1l1 Is an Early Biomarker of Liver Fibrosis in CCl4-treated Rats

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2016English

Blood Microbiota as a Potential Noninvasive Diagnostic Biomarker for Liver Fibrosis in Severely Obese Patients: Choose Carefully

Hepatology
MedicineHepatology
2017English

FABP1 as a Novel Potential Biomarker for Predicting Mortality in Acetaminophen-Induced Acute Liver Failure

Hepatology
MedicineHepatology
2017English

Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

TRIF as a Novel Modulator of Liver Inflammation and Fibrosis

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Liver-Specific Loss of Perilipin 2 Alleviates Diet-Induced Hepatic Steatosis, Inflammation, and Fibrosis

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2016English

Liver Fibrosis Is Not Associated With Steatosis but With Necroinflammation in French Patients With Chronic Hepatitis C

Gut
Gastroenterology
2003English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology
Forensic MedicinePathology
2012English

Fatty Liver (Liver Steatosis)

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy